ANCO upcoming events

ANCO's Ping-Pong & Networking (11/06/2026)

Sat, 07 Nov 2026 02:00:00 GMT

ANCO is putting a new spin on networking! Join us at SPIN SF in SoMa on Friday, November 6th (the night before the Precision Oncology) for an evening of ping-pong, camaraderie, and connection. This event is curated specifically for our practitioner community to relax and connect before the symposium begins—and families and kids are welcome to join the fun!

When: Friday, November 6th at 6:00 PM
Where: SPIN SF (SoMa)
What to Expect: Show up ready to rally! Enjoy open ping-pong tables, hosted food, and drinks while catching up with colleagues in a fun, relaxed environment.

Registration

ANCO Members: $0
Guests: $30
Families & Children: Welcome!
Eligibility Note: Reserved for practitioner members not affiliated with industry.

ANCO & MOASC Present: Precision Oncology Symposium (11/07/2026)

Sat, 07 Nov 2026 16:00:00 GMT

Join us for ANCO & MOASC Present: Precision Oncology Symposium 2026 taking place at the InterContinental San Francisco, November 7, 2026!

Meeting Overview:

Transforming Tumor Profiling into Targeted Patient Care.

Precision oncology is rapidly changing the landscape of cancer care. With FDA approvals shifting toward molecular features rather than disease location, personalized treatment is no longer just a goal—it’s the standard.

However, with diagnostic technologies and targeted therapies evolving at a breathtaking pace, keeping up with clinical applications remains a challenge. Join ANCO & MOASC for an immersive symposium designed to help practicing oncologists and clinical care teams bridge the gap between cutting-edge diagnostics and patient outcomes.

Learning Objectives:

By participating this meeting, attendees will learn to:

Translate complex molecular tumor profiles and tumor-agnostic FDA approvals into personalized patient treatment plans.
Navigate current challenges and adopt new therapeutic opportunities in Gastrointestinal, Genitourinary, Lung, and Breast/Gynecologic cancers.
Utilize germline data alongside somatic diagnostic findings to guide comprehensive clinical decision-making.
Identify cross-tumor challenges in precision testing and apply best practices to overcome diagnostic barriers.
Partner with patient advocates to ensure biomarker-driven care plans remain patient-centered and accessible.

ANCO Board of Directors Meet & Greet - Diamond, Sustaining and Sustaining Plus (12/19/2026)

Sun, 20 Dec 2026 01:30:00 GMT

Thank you for being a valued corporate member of ANCO. As a benefit of your Sustaining Plus, Sustaining, or Diamond corporate membership, we’re pleased to invite you to our annual ANCO Corporate Member Reception with the Board of Directors. Each organization may be represented by up to three (3) attendees.

27th Multidisciplinary Management of Cancers: A Case-Based Approach (03/19/2027)

Fri, 19 Mar 2027 07:00:00 GMT

Join us at the 27th Multidisciplinary Management of Cancers: A Case-Based Approach!

Meeting Overview:

The 27th Multidisciplinary Management of Cancers: A Case-Based Approach meeting will present the most current information on multidisciplinary approaches in clinical oncology. It will consist of tumor board cases covering breast, central nervous system, hematologic malignancies, gastrointestinal, genitourinary, lymphoma, melanoma, supportive oncology and survivorship, and thoracic cancers.

Faculty will present the tumor board cases, followed by a discussion with a panel of surgical, radiation, and medical oncologists from Stanford, UC Davis, UC San Francisco, The Permanente Medical Group, and the practice community.

Learning Objectives:

Develop multidisciplinary treatment strategies based on national clinical practice guidelines in oncology in order to improve quality of care for cancer patients.
Discuss relevant clinical trials with cancer patients and refer appropriately.

EXHIBIT OPPORTUNITY: 27th Multidisciplinary Management of Cancers: A Case-Based Approach (03/19/2027)

Fri, 19 Mar 2027 14:30:00 GMT

Exhibitor registration is not yet open. Registration will open to ANCO 2027 Corporate Members the week of October 26.

If space remains available, registration will open to non-member organizations in January 2027.

Exhibitor Information

Event Details:
Date: March 19–21, 2027
Location: Hyatt Regency Monterey Hotel and Spa, 1 Old Golf Course Road, Monterey, CA 93940

Support for this meeting is being sought at two levels from our ANCO 2027 Corporate Members:

Major Exhibitor: includes an exhibit table with first-choice location selection, 3 exhibitor badges, and premier recognition for a fee of $12,000 for members and $14,500 for non-members.
Exhibitor: includes an exhibit table and 2 exhibitor badges for a fee of $8,500 for members and $10,250 for non-members.

This event is not open to non-members yet, but the pricing is as follows: Major Exhibitor Non-Member Exhibitor - $14,500 and Standard Exhibitor - $10,250.

Please click the links below to access the necessary documents:

LOR - 27th Multidisciplinary Management of Cancers 2027 Exhibit

Draft Agenda - 27th Multidisciplinary Management of Cancers 2027

ANCO W-9

How to Secure Your Space:
Exhibit space is limited and assigned on a first come, first served basis. Our exhibitor agreement is online and completing the online exhibitor registration is the ONLY way to secure your spot. Please follow the steps below to reserve your spot. (If you have trouble logging in, email ashley@anco.org).

To Complete the Exhibitor Agreement: Click Register button (top right), enter your email, and click Next to complete and submit your form.
Note: If you need any internal documents, agreements, or forms signed on our end to get your funding approved, please email them to ashley@anco.org and we will gladly sign them to expedite the process.
Submit Payment: On the last page of the online exhibitor agreement, choose how you’d like to pay:
Credit card: Your payment is processed immediately. A 3.08% processing fee applies.
Invoice me: Your exhibit space is confirmed, and you’ll receive an invoice to pay by check, ACH, or credit card.
To finalize your reservation, full payment must be received by March 5, 2027. ANCO reserves the right to release your exhibit space to another company if payment is not received in full by this date.

Please make checks payable to ANCO and mail them to 4225 Solano Avenue, #764, Napa, CA 94558. ANCO’s FEIN is 68-0213997.

ANCO Exhibitor Payment & Cancellation Policy:
Payment Terms: All exhibitor payments must be received in full by March 5, 2027.

Cancellations prior to [March 5, 2027]: written cancellation requests received before [March 5, 2027] will be refunded, minus a 10% administrative fee.
Cancellations on or after [March 5, 2027]: no refunds will be issued for cancellations received on or after [March 5, 2027].
Unpaid agreements: canceling an exhibitor agreement prior to ANCO receiving payment does not release the exhibitor from liability for outstanding funds due based on this policy.

Hematologic Malignancies Update 2027 (05/01/2027)

Sat, 01 May 2027 07:00:00 GMT

Join us for Hematologic Malignancies Update taking place at the Hyatt Regency Monterey, May 1-2, 2027!

Meeting Overview

Turn the latest cancer research into better patient care.

Join a community of oncology professionals for two days of practical insights, emerging therapies, and evidence-based strategies you can bring directly into your practice. From evolving treatment approaches to symptom management and supportive care, this meeting is designed to help you stay ahead of the science, strengthen clinical decision-making, and deliver more personalized, patient-centered cancer care.

Connect with fellow clinicians, nurses, and PAs to exchange perspectives, explore new approaches, and translate the latest advances into meaningful outcomes for your patients.

Learning Objectives

By the end of this meeting, participants will be able to:

Apply evidence-based treatment strategies aligned with national oncology clinical practice guidelines to enhance the quality of cancer care.
Identify effective approaches to pain management and counsel patients on appropriate pharmacologic and psychiatric strategies.
Evaluate relevant clinical trials and identify opportunities for patient participation and appropriate referral.
Integrate palliative care into cancer treatment by recognizing when referral is appropriate to support quality of life throughout the cancer journey.